SPARC Health Announces Second Cohort Applications, Building on Inaugural Program Success

SALT LAKE CITY, JANUARY 15, 2026—SPARC Health, a collaborative effort between Park City Angels (PCA), BioUtah, BioHive, in partnership with Governor’s Office of Economic Opportunity (GOEO), today announced applications are now open for its second cohort program. The announcement celebrates the impressive achievements of the inaugural cohort and the growing momentum of Utah’s healthcare innovation […]

Read More

SPARC Health and BioUtah to Co-Host Shark Tank-Style Pitch Competition at 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit

3 Key takeaways   Participants gain a rare platform to pitch to a specialized panel of judges who possess the deep industry expertise required to fund and scale complex medical technologies, pharmaceuticals, and digital health solutions. Following in March, after the global JPMorgan Healthcare Conference, participating companies can take the “JPM momentum” and apply it […]

Read More

Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever

SALT LAKE CITY, UT (Business Wire) – Seek Labs, a biotechnology company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the publication of a peer-reviewed paper in Viruses (MDPI), revealing the first successful use of a CRISPR-based therapeutic to treat African Swine Fever Virus (ASFV) in pigs. The […]

Read More

Owlet and Locus Health Partner to Seamlessly Deliver Infant Health Data into Remote Patient Monitoring Programs

This first-of-its-kind infant care collaboration for Owlet enables clinicians to access Owlet’s data through Locus Health’s platform, enhancing visibility, improving care continuity, and supporting families after hospital discharge. LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces a partnership with Locus Health, a leader in […]

Read More

ARUP Advocates for the RESULTS Act To Protect Patient Access to Critical Laboratory Testing Services

SALT LAKE CITY, November 19, 2025— With a deadline approaching on January 31, 2026, ARUP Laboratories has joined other clinical laboratories in advocating for passage of the federal Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, which would block looming cuts in payments for lab testing services, relieve labs of burdensome reporting, […]

Read More

Recap: 2025 Mayer Brown Utah Life Sciences Summit

The 2025 BioUtah Utah Life Sciences Summit (ULSS) took place November 12 at the Hilton Salt Lake City Center, featuring keynote speakers, awards, educational sessions, networking opportunities, and the signing of a Memorandum of Understanding (MOU) with the Korea Health Industry Development Institute. With 650 registrants, this year’s Summit was the biggest yet. Jefferson Moss, […]

Read More

BioUtah Life Sciences Delegation Showcases Utah Innovation in Australia

As part of Governor Spencer Cox’s Australia Trade Mission from October 19–25, BioUtah led a focused Life Sciences Track highlighting Utah’s growing global leadership in biotechnology, medtech, diagnostics, and health innovation. The delegation met with prominent Australian partners, investors, and regulators to explore opportunities for collaboration and market expansion. Companies participating in the trade mission […]

Read More

Seek Labs Expands Global Disease Atlas to Include Hemorrhagic Fever Viruses

    Salt Lake City, Utah – October 21, 2025 Salt Lake City-based biotech firm Seek Labs announced today that it has expanded its Global Disease Atlas™ to include several of the world’s deadliest hemorrhagic fever viruses (HFVs) — namely, Ebola virus, Marburg virus, Lassa virus, Hantavirus, Crimean‑Congo hemorrhagic fever virus (CCHFV), and Rift Valley fever virus (RVFV). In July, the company announced that it […]

Read More

Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes

Posted on

LEHI, Utah, Oct. 23, 2025 /PRNewswire/ — Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes of inflammation-driven diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its investigational medicine ofirnoflast (HT-6184) for the treatment of Myelodysplastic Syndromes (MDS) — a group […]

Read More

 Journal of Clinical Microbiology Publishes Article on ARUP’s Validation of AI for Parasite Detection 

SALT LAKE CITY, October 21, 2025— ARUP Laboratories today announced the publication of an article in the Journal of Clinical Microbiology describing the company’s validation of a deep convolutional neural network (CNN) to detect parasites in concentrated wet mounts of stool.  For decades, detection of gastrointestinal parasites has relied on traditional microscopy, which is a […]

Read More

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

Posted on

SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced ceramics specializing in biomedical applications of silicon nitride (Si₃N₄), today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the SINAPTIC® Foot & Ankle Osteotomy Wedge System, enabling SINTX’s commercial entry […]

Read More

Nucleus Grow Hosts State of Innovation Conference

The State of Innovation Conference, hosted by The Nucleus Institute, brought together entrepreneurs, investors, policymakers, and researchers to explore pathways, partnerships, and funding strategies for breakthrough technologies. The day began with keynote speaker Jerry Hollister, who spoke on federal innovation funding trends, followed by a panel highlighting Utah companies that had successfully leveraged SBIR/STTR awards, […]

Read More